Thursday, October 29, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

NCT07758231 · PHASE1 · NOT YET RECRUITING · Sponsor: University of Wisconsin, Madison · Conditions: GLP-1,

PR
By Priya Raman · Science Reporter
Oct 29 08:00 ETSource: ClinicalTrials.gov

From the source

Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

NCT07758231 · PHASE1 · NOT YET RECRUITING · Sponsor: University of Wisconsin, Madison · Conditions: GLP-1, Alcohol.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →